Ken Fisher acquired 13.7 Million Novo Nordisk shares worth $1.76 Billion. That's 0.84% of their equity portfolio (35th largest holding). The first Novo Nordisk trade was made in Q1 2013. Since then Ken Fisher bought shares 22 more times and sold shares on 22 occasions. The stake costed the investor $603 Million, netting the investor a gain of 192% so far.